Each prefilled syringe contains 105 mg of romosozumab in 1.17 ml of solution (90 mg/ml).
Romosozumab is a humanized IgG2 monoclonal antibody produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells.
Excipients/Inactive Ingredients: Calcium acetate, Glacial acetic acid, Sodium hydroxide (for pH adjustment), Sucrose, Polysorbate 20, Water for injections.